The DRP5A antibody is a research tool used to detect and study the DRP5A protein in various organisms, particularly in plants like Arabidopsis thaliana . DRP5A, or Dynamin-Related Protein 5A, is involved in cell division, specifically cytokinesis, the process where a cell divides into two daughter cells .
DRP5A antibodies are generated using immunofluorescence microscopy, where animals are immunized with DRP5A protein or a fragment of it, which stimulates the animal's immune system to produce antibodies against DRP5A . These antibodies are then collected and purified for use in research. Genetic immunization techniques can also be employed to generate anti-DR4 and anti-DR5 antibodies, which involves injecting DR4 and DR5 cDNA into the tail veins of mice . Resulting hybridomas are screened by ELISA to identify antibody-secreting clones .
The DRP5A antibody is designed to specifically bind to the DRP5A protein. This allows researchers to visualize the location and study the function of DRP5A within cells .
Localization Studies: Researchers use DRP5A antibodies to determine where the DRP5A protein is located within cells. In Arabidopsis thaliana, the DRP5A protein is found at the cell plate during cytokinesis .
Cell Cycle Analysis: The antibody helps track the expression and localization of DRP5A throughout the cell cycle. Studies have shown that DRP5A expression is specific to the M phase (mitosis) of the cell cycle .
Functional Studies: By using the DRP5A antibody, researchers can investigate the role of DRP5A in cytokinesis. Mutant analyses using insertional mutant lines of Arabidopsis thaliana have been performed to understand DRP5A’s function during cell division .
Cytokinesis Involvement: DRP5A is involved in cytokinesis in Arabidopsis thaliana .
Cell Cycle Specificity: DRP5A protein expression is specific to the M phase of the cell cycle .
Localization: During cell division, DRP5A localizes to speckles around the nucleus in prophase, disperses in the cytosol during metaphase, and concentrates at the cell plate in telophase .
Functional Redundancy: Arabidopsis thaliana contains other dynamin proteins that may have functional redundancy with DRP5A .
Interaction with Other Proteins: DRP5B can interact or form a complex with itself and with DRP3A, DRP3B, FIS1A, and most of the Arabidopsis .
DRP5A is a dynamin-related protein that functions in plant cytokinesis rather than chloroplast division. Studies with DRP5A-GFP and anti-DRP5A antibodies have shown that DRP5A localizes to the cell plate during cytokinesis, with expression limited to dividing cells in meristematic tissues. Immunofluorescence microscopy has revealed that DRP5A exhibits a cell cycle-dependent localization pattern, with speckles appearing around the nucleus during prophase and eventually accumulating at the cell plate during late telophase . M phase-specific accumulation of DRP5A mRNA has been detected through cell cycle synchronization in Arabidopsis thaliana cultured cells, indicating that DRP5A expression is tightly regulated during the cell cycle .
DRP5A belongs to a family of dynamin-related proteins that includes DRP5B, its closest relative. Despite their structural similarity, these proteins have distinct functions:
| Protein | Primary Function | Localization | Evolutionary Distribution |
|---|---|---|---|
| DRP5A | Cytokinesis | Cell plate | Viridiplantae, Amoebozoa, Heterolobosea |
| DRP5B | Chloroplast and peroxisome division | Chloroplasts, peroxisomes | Archaeplastida |
| DRP1/2 | Post-Golgi traffic, endocytosis | Plasma membrane, endocytic vesicles | DRP1: Viridiplantae; DRP2: Embryophyta |
| DRP3 | Mitochondrial division | Mitochondria | Wide range of Eukaryota |
Unlike DRP5B, which localizes to both chloroplasts and peroxisomes and is involved in their division, DRP5A is specifically involved in cytokinesis . The phylogenetic distribution of DRP5A (found in Viridiplantae, Amoebozoa, and Heterolobosea) suggests an ancient role in cell division mechanisms that has been conserved in multiple evolutionary lineages .
Several approaches can be used to generate DRP5A-specific antibodies for research:
Recombinant protein immunization: Expression of full-length or partial DRP5A protein in systems like E. coli, yeast, or baculovirus for immunization . This approach provides a well-defined immunogen but may face challenges with large proteins like DRP5A (~90 kDa).
Synthetic peptide approach: Selection of unique peptide sequences (typically 15-20 amino acids) from DRP5A regions with minimal similarity to DRP5B, conjugated to carrier proteins for immunization. This method enables targeting of specific domains but may not capture conformational epitopes.
Phage display technology: Creation of antibody libraries displayed on phage surfaces followed by selection (biopanning) against purified DRP5A . This technique can yield high-affinity antibodies without animal immunization.
For maximum specificity, antibodies should target regions with the least homology to DRP5B, such as portions of the middle domain or the C-terminal region, to minimize cross-reactivity with this close homolog.
Comprehensive validation of DRP5A antibodies requires several critical controls:
| Control Type | Specific Examples | Purpose |
|---|---|---|
| Negative Controls | drp5a null mutant samples | Establish baseline for non-specific binding |
| Pre-immune serum or isotype controls | Assess background from antibody source | |
| Secondary antibody-only | Evaluate secondary antibody background | |
| Peptide competition assays | Confirm epitope specificity | |
| Positive Controls | Wild-type tissues (root tips, meristems) | Verify detection in known expression sites |
| Recombinant DRP5A protein | Standard for Western blot validation | |
| DRP5A-GFP transgenic lines | Confirm co-localization pattern | |
| Specificity Controls | drp5b mutant samples | Rule out cross-reactivity with closest homolog |
| Immunoprecipitation with mass spectrometry | Confirm target identity | |
| Cross-reactivity testing with other DRPs | Assess family-wide specificity |
Validation should include multiple experimental approaches (Western blot, immunofluorescence, immunoprecipitation) to ensure the antibody performs consistently across applications . When conducting studies in drp5a mutants, it's crucial to include wild-type controls processed under identical conditions to accurately assess phenotypic differences .
Optimized immunofluorescence protocol for DRP5A visualization:
Sample preparation:
Use actively dividing tissues (root tips, shoot apical meristems)
Fix in 4% paraformaldehyde in a suitable buffer (e.g., MTSB or PBS)
Digest cell walls with cellulase/pectinase for antibody penetration
Immunolabeling strategy:
Permeabilize with 0.1-0.5% Triton X-100
Block with 3-5% BSA or normal serum
Incubate with validated anti-DRP5A antibody at optimized dilution
Use appropriate fluorophore-conjugated secondary antibody
Co-labeling recommendations:
Label with anti-tubulin antibodies to visualize the phragmoplast
Include DNA staining (DAPI) to determine mitotic stages
Consider co-labeling with cell plate markers
Imaging considerations:
When analyzing DRP5A localization, it's essential to precisely identify cell cycle stages through appropriate markers, as DRP5A localization changes dramatically from prophase (speckles around the nucleus) to telophase (concentrated at the cell plate) .
Optimized Western blot protocol for DRP5A detection:
Sample preparation:
Extract from tissues with high DRP5A expression (meristematic regions)
Use extraction buffer containing protease inhibitors
Include phosphatase inhibitors to preserve modifications
Clear lysates by centrifugation (13,000-15,000 × g)
Protein separation:
Use 8-10% SDS-PAGE gels for optimal separation of DRP5A (~90 kDa)
Load 20-50 μg total protein per lane
Include appropriate molecular weight markers
Transfer conditions:
Wet transfer: 30V overnight at 4°C
Use 0.45 μm PVDF membranes
Add 0.1% SDS to transfer buffer to improve large protein transfer
Antibody incubation:
Block with 5% non-fat dry milk or 3% BSA in TBST
Incubate with primary antibody overnight at 4°C (1:1000-1:5000)
Wash extensively (5 × 5 minutes)
Incubate with HRP-conjugated secondary antibody (1:5000-1:10000)
Detection:
Use enhanced chemiluminescence for sensitive detection
Consider fluorescent secondary antibodies for quantification
For troubleshooting weak signals, consider enriching for dividing cells or using colchicine treatment to increase DRP5A abundance, as its expression is limited to M-phase cells .
Multiple complementary approaches can be used to study DRP5A interactions:
| Method | Principle | Advantages | Limitations |
|---|---|---|---|
| Co-immunoprecipitation (Co-IP) | Pull-down of native protein complexes using DRP5A antibodies | Detects native interactions | May miss transient interactions |
| Yeast Two-Hybrid (Y2H) | Binary interaction detection in yeast | High-throughput screening | May give false positives/negatives |
| Bimolecular Fluorescence Complementation (BiFC) | Reconstitution of split fluorescent protein | Visualizes interactions in planta | Irreversible complementation |
| FRET/FLIM | Energy transfer between fluorophores | Detects dynamic interactions | Requires specialized equipment |
| Proximity-dependent biotin identification (BioID) | Biotinylation of proximal proteins | Captures transient interactions | May detect proximity not interaction |
Research has shown that dynamin-related proteins can form both homo-oligomers and hetero-oligomers. For instance, Y2H assays have demonstrated that some plant DRPs can interact with structurally distinct DRPs to form hetero-polymers . When using antibodies for interaction studies, consider whether the antibody epitope might interfere with protein-protein interaction interfaces.
When facing discrepancies between antibody-based and GFP-fusion localization patterns for DRP5A, a systematic approach is needed:
Potential causes of discrepancies:
Fixation artifacts in immunostaining
GFP tag interference with protein function
Expression level differences between native and transgenic proteins
Epitope masking in specific protein complexes
Temporal dynamics captured differently by each method
Resolution strategies:
Compare multiple fixation methods
Test both N- and C-terminal GFP fusions
Generate transgenic lines with native promoter expression
Perform complementation tests in drp5a mutants with GFP-DRP5A
Use multiple antibodies recognizing different epitopes
Employ super-resolution microscopy for detailed localization
In studies of DRP5A, both approaches have provided valuable insights. GFP-DRP5A expressed under the DRP5A promoter successfully complements drp5a mutant phenotypes, suggesting functional protein folding and localization . Comparison of DRP5A-GFP fusion protein results with antibody immunofluorescence has shown consistent localization patterns, with both methods revealing speckles and bar-shaped structures during cell division .
DRP5A antibodies provide powerful tools for studying cell cycle regulation:
Expression dynamics analysis:
Quantify DRP5A levels across cell cycle stages using immunoblotting
Correlate with cell cycle markers to establish precise timing
Compare wild-type with cell cycle mutants to identify regulatory pathways
Cell cycle synchronization studies:
Use aphidicolin or colchicine treatments with immunoblotting
Track DRP5A abundance after cell cycle release
Identify post-translational modifications by mobility shifts
Post-translational modification mapping:
Develop phospho-specific antibodies for DRP5A
Combine with phosphatase treatments to confirm specificity
Map cell cycle-dependent modifications
Regulatory pathway analysis:
Immunoprecipitate DRP5A to identify cell cycle-dependent interaction partners
Examine effects of CDK inhibitors on DRP5A localization
Combine with genetic approaches using cell cycle mutants
Research has shown that DRP5A expression is highly regulated during the cell cycle, with M phase-specific accumulation of both mRNA and protein. Colchicine treatment to arrest cells in M phase results in most root tip cells displaying DRP5A fluorescence, while aphidicolin treatment (S-phase arrest) results in minimal signal , confirming tight cell cycle regulation.
Environmental factors significantly impact DRP5A dynamics:
Understanding how DRP5A responds to environmental stresses provides insights into how plants adapt their cell division machinery to changing conditions. The temperature sensitivity of drp5a mutants suggests that DRP5A function may be particularly important under suboptimal growth conditions .
DRP5A conservation across plant lineages can be investigated using antibodies:
Cross-species antibody applications:
Test reactivity against DRP5A orthologs in diverse plant species
Develop antibodies targeting highly conserved epitopes
Compare localization patterns during cytokinesis across lineages
Experimental design for evolutionary studies:
Perform side-by-side immunolocalization in related species
Combine with cytoskeletal markers to normalize cell division stages
Include phylogenetically diverse sampling across major plant groups
Epitope conservation analysis:
Map antibody recognition to sequence conservation patterns
Correlate functional constraints with epitope conservation
Identify species-specific variations in DRP5A sequences
DRP5A is found in Viridiplantae (green plants), Amoebozoa, and Heterolobosea, suggesting its ancestral role in cytokinesis evolved before the divergence of these lineages . While DRP5A function in cytokinesis appears conserved, specific mechanisms and interactions may vary across plant families, making comparative studies valuable for understanding cytokinesis evolution.
| Issue | Possible Causes | Solutions |
|---|---|---|
| Weak or no signal in Western blots | Low DRP5A expression | Use dividing tissues; enrich M-phase cells with colchicine |
| Inefficient extraction | Try different extraction buffers with non-ionic detergents | |
| Improper transfer | Optimize transfer for large proteins; use 0.1% SDS in transfer buffer | |
| Degradation | Add fresh protease inhibitors; keep samples cold | |
| High background in immunofluorescence | Insufficient blocking | Increase blocking time; try different blocking agents |
| Non-specific antibody binding | Pre-absorb antibody; purify IgG fraction | |
| Autofluorescence | Use specific filters; try different fixatives | |
| Multiple bands in Western blot | Degradation products | Add protease inhibitors; reduce extraction time |
| Cross-reactivity | Affinity-purify antibody; test peptide competition | |
| Post-translational modifications | Test phosphatase treatment; use PhosTag gels | |
| Inconsistent localization patterns | Cell cycle variation | Synchronize cells; co-stain with cell cycle markers |
| Fixation artifacts | Compare multiple fixation methods | |
| Epitope masking | Test different antibodies to various epitopes |
When troubleshooting DRP5A experiments, remember that its expression is highly cell cycle-dependent and restricted to dividing cells, which can lead to challenges in detection in tissues with low division rates .
Epitope mapping provides critical information for antibody optimization:
Mapping techniques:
Peptide array analysis using overlapping peptides
Deletion/truncation mapping with recombinant fragments
Site-directed mutagenesis of predicted epitope regions
Hydrogen-deuterium exchange mass spectrometry
Applications of epitope knowledge:
Design more specific antibodies targeting unique regions
Develop antibodies recognizing specific conformational states
Create phospho-specific antibodies for regulatory studies
Engineer cross-species reactive antibodies for evolutionary studies
Specificity optimization:
Create antibodies targeting regions with minimal homology to DRP5B
Design epitopes avoiding conserved GTPase domains
Develop antibodies recognizing unique post-translational modifications
For DRP5A, targeting regions outside the highly conserved GTPase domain is essential for generating specific antibodies that don't cross-react with DRP5B or other dynamin-related proteins. The middle domain and C-terminal regions typically have lower sequence conservation among dynamin family members and may provide better targets for specific antibody development .
Accurate quantification of DRP5A requires tailored approaches:
Western blot-based quantification:
Use standard curves with recombinant DRP5A protein
Employ fluorescent secondary antibodies for linear detection
Normalize to stable reference proteins
Utilize digital imaging with quantification software
ELISA development:
Create sandwich ELISA using antibodies to different epitopes
Develop standard curves with recombinant protein
Optimize sample preparation to minimize matrix effects
Mass spectrometry approaches:
Develop selected reaction monitoring (SRM) assays
Use isotope-labeled peptide standards for absolute quantification
Select DRP5A-specific peptides with good ionization properties
Flow cytometry for single-cell analysis:
Optimize protoplast preparation protocols
Perform intracellular staining with DRP5A antibodies
Include cell cycle markers for population segregation
When quantifying DRP5A, it's essential to account for its cell cycle-regulated expression pattern. Normalizing to the proportion of dividing cells in each sample is critical for meaningful comparisons between tissues with different rates of cell division .
Several approaches can evaluate how antibodies affect DRP5A function:
Microinjection studies:
Inject DRP5A antibodies into living cells
Monitor effects on cytokinesis and cell plate formation
Use fluorescently-labeled antibodies to track localization
Cell-penetrating antibody fragments:
Engineer Fab or scFv fragments with cell-penetrating peptides
Apply to dividing tissues and observe cytokinesis effects
Combine with live cell imaging of cell plate markers
Experimental design considerations:
Include non-specific antibody controls
Titrate antibody concentrations to determine dose-response
Use multiple antibodies targeting different epitopes
Compare effects to genetic knockdowns for validation
Readout systems:
Quantify completed vs. aborted cytokinesis events
Measure cell plate formation dynamics
Track chromosomal segregation errors
Assess multinucleation as indicator of cytokinesis failure
When designing such experiments, it's important to consider whether the antibody epitope corresponds to functionally important domains of DRP5A, such as the GTPase domain or regions involved in protein-protein interactions. Antibodies targeting different functional domains may produce distinct phenotypic effects .